Cytyc announces convertability of 2¼% senior notes due 2024

By Devika Patel

Knoxville, Tenn., July 19 - Cytyc Corp. announced that it is notifying the holders of its 2¼% senior convertible notes due 2024 that they may convert their holdings at any time through maturity.

The notes became convertible because the closing sale price of Cytyc stock exceeded 120% of the notes' conversion price for at least 20 of the last 30 trading days in the last quarter. The conversion price of the notes is $29.67.

Cytyc is a Marlborough, Mass., diagnostic and medical device company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.